Treatment of severe ulcerative colitis: Differences in elderly patients?

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 315-321

  Vavricka, Stephan R ^a   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cyclosporine; Infliximab; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTISONE; CYCLOSPORIN A; HYDROCORTISONE; INFLIXIMAB; MEPREDNISONE; PLACEBO; PREDNISOLONE; TACROLIMUS;

AGED; CLINICAL TRIAL; COLON RESECTION; COMORBIDITY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DRUG HALF LIFE; HUMAN; PRIORITY JOURNAL; SALVAGE THERAPY; TOXIC MEGACOLON; ULCERATIVE COLITIS;

AGED; AGING; COLITIS, ULCERATIVE; HUMANS;

EID: 70349905350     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228567     Document Type: Conference Paper

References (41)

1. Grimm IS, Friedman LS: Inflammatory bowel disease in the elderly. Gastroenterol Clins North Am 1990; 19: 361-389.
2. Brandt LJ, Dickstein G: Inflammatory bowel disease: specific concerns in the elderly. Geriatrics 1989; 44: 107-111. (Pubitemid 19107636)
3. Sedlack RE, Nobrega FT, Kurland LT, Sauer WG: Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology 1972; 62: 935-941.
4. Bonnevie O, Riis P, Anthonisen P: An epidemiological study of ulcerative colitis. Scand J Gastroenterol 1968; 3: 432-438.
5. De Dombal Fr, Burch PR, Watkinson G: Aetiology of ulcerative colitis. Gut 1969; 10: 270-277.
6. Sinclair TS, Brunt PW, Mowat NA: Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983; 85: 1-11.
7. Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF: European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2: 1-23. (Pubitemid 351179487)
8. Travis SP, Stange EF, Lémann M, Oresland T, Bemelman WA, Chowers Y, Colombel JF, D'Haens G, Ghosh S, Marteau P, Kruis W, Mortensen NJ, Penninckx F, Gassull M: European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008;2:24-62. (Pubitemid 351179488)
9. Biancone L, Michetti P, Travis S, Escher JC, Moser G, Forbes A, Hoffmann JC, Dignass A, Gionchetti P, Jantschek G, Kiesslich R, Kolacek S, Mitchell R, Panes J, Soderholm J, Vucelic B, Stange E: European evidence-based consensus on the management of ulcerative colitis: special situations. J Crohns Colitis 2008; 2: 63-92. (Pubitemid 351179489)
10. Truelove SC, Witts LJ: Cortisone in ulcerative colitis. Br Med J 1955;ii:1041-1048.
11. Truelove SC, Jewell DP: Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;i:1067-1070.
12. Truelove SC, Willoughby CP, Lee EG, Kettlewell MG: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;ii:1086-1088. (Pubitemid 9052873)
13. Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J: The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004; 10: 245-250. (Pubitemid 38618254)
14. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Ha - nauer S: Cyclosporine in severe acute ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-1845. (Pubitemid 24188135)
15. D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, Peeters M, Vermeire S, Penninckx F, Nevens F, Hiele M, Rutgeerts P: Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001; 120: 1323-1329. (Pubitemid 32322305)
16. Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, Arts J, D'Hoore A, Penninckx F, Rutgeerts P: Randomized double-blind controlled comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003; 125: 1025-1031. (Pubitemid 37193449)
17. Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B: Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-1811. (Pubitemid 40824691)
18. Ogata H, Matsui T, Nakamura M, Iida M, Takazoe MM, Suzuki Y, Hibi T: A randomized dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006; 55: 1255-1262. (Pubitemid 44277355)
19. Järnerot G, Rolny P, Sandberg-Gertzén H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005-1013. (Pubitemid 16231562)
20. Meyers S, Janowitz HD: Systemic corticosteroid therapy of ulcerative colitis. Gastroenterology 1985; 89: 1189-1191. (Pubitemid 16231587)
21. Turner D, Walsh CM, Steinhart AH, Griffiths AM: Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 5: 103-110. (Pubitemid 46096828)
22. Powell-Tuck J, Buckell NA, Lennard-Jones JE: A controlled comparison of corticotrophin and hydrocortisone in the treatment of severe proctocolitis. Scand J Gastroenterol 1977; 12: 971-975. (Pubitemid 8257824)
23. Meyers S, Sachar DB, Goldberg JD, Janowitz HD: Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology 1983; 85: 351-357.
24. Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD: Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, doubleblind clinical trial. J Clin Gastroenetrol 1987; 9: 50-54. (Pubitemid 17035259)
25. Rodriguez-D'Jesus A, Casellas F, Malagelada JR: Epidemiology of inflammatory bowel disease in the elderly. Gastroenterol Hepatol 2008; 31: 269-273. (Pubitemid 351670886)
26. Riegler G, Tartaglione MT, Carratu R, D'Inca R, Valpiani D, Russo MI, Papi C, Fiorentini MT, Ingrosso M, Andreoli A, Vecchi M: Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-465. (Pubitemid 30171918)
27. Sandborn WJ: A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995; 1: 48-63.
28. Actis GC, Ottobrelli A, Pera A, Barletti C, Ronti V, Pinna-Pintor M, Verme G: Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 1993; 17: 10-13. (Pubitemid 23193769)
29. Carbonnel F, Boruchowicz A, Duclos B, Soulé JC, Lerebours E, Lémann M, Belaiche J, Colombel JF, Cosnes J, Gendre JP: Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996; 41: 2471-2476. (Pubitemid 27041805)
30. Kornbluth A, Present DH, Lichtiger S, Hanauer S: Cyclosporine for severe ulcerative colitis: a user's guide. Am J Gastroenterol 1997; 92: 1424-1428. (Pubitemid 27412859)
31. Campbell S, Travis S, Jewell D: Cyclosporine use in acute ulcerative colitis: a long term experience. Eur J Gastroenterol Hepatol 2005; 17: 79-84. (Pubitemid 40128931)
32. Fernandez-Banares F, Bertran X, Esteve-Comas M, Cabre E, Menacho M, Humbert P, Planas R, Gassull MA: Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Am J Gastroenterol 1996; 91: 2498-2499. (Pubitemid 26406297)
33. Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K: Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev 2005; 1: CD004277.
34. Cohen RD, Brodsky AL, Hanauer SB: A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporine. Inflamm Bowel Dis 1999; 5: 1-10.
35. Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P: Long-term outcome of treatment with intravenous cyclosporine in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004; 10: 73-78. (Pubitemid 38332164)
36. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns S, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476. (Pubitemid 41770166)
37. Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A: Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci 2004; 8: 231-233. (Pubitemid 39654526)
38. Ochsenkühn T, Sackmann M, Göke B: Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol 2004; 16: 1167-1171.
39. Probert CS, Hearing SD, Schreiber S, Kuhbacher T, Ghosh S, Arnott ID, Forbes A: Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomized controlled trial. Gut 2003; 52: 998-1002. (Pubitemid 36765292)
40. Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK: Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001; 7: 83-88. (Pubitemid 32998493)
41. Condie JD Jr, Laslie KO, Smiley DF: Surgical treatment for inflammatory bowel disease in the older patient. Surg Gynecol Obstet 1987; 165: 135-142. (Pubitemid 17151740)